4 . 
research should fall also on these other interests (e.g. NSF, DOE, USDA) . 
I would suggest that this could be practically accomplished by investing 
more authority in the Recombinant DNA Advisory Committee and making that 
committee responsible to a committee of appropriate interested agencies. 
Indeed, the NIH has done a remarkably good job of handling the 
recombinant DNA issue. However, I believe that it is a strength of American 
science that there are multiple interests and multiple resources to fund 
scientific endeavors. I should not like to see this option eliminated or 
diminished by restricting the authority for regulating a technique with 
broad potential applicability. 
Gentlemen, I thank you for your interest and patience. 
Dr. Carl W. Anderson 
Associate Scientist 
Biology Department 
Brookhaven National Laboratory 
Upton, New York 
[ 386 ] 
